Mutually exclusive splicing of exons is a mechanism of functional gene and protein diversification with pivotal roles in organismal development and diseases such as Timothy syndrome, cardiomyopathy and cancer in humans. In order to obtain a first genome-wide estimate of the extent and biological role of mutually exclusive splicing in humans we predicted and subsequently validated mutually exclusive exons (MXEs) using 515 publically available RNA-seq datasets. Here, we provide evidence for the expression of over 855 MXEs, 42% of which represent novel exons, increasing the annotated human mutually exclusive exome more than five-fold. The data provides strong evidence for the existence of large and multi-cluster MXEs in higher vertebrates and offers new insights into MXE splicing mechanics and evolution. Finally, MXEs are significantly enriched in pathogenic mutations and their spatio-temporal expression predicts human disease pathology.
Introduction
Alternative splicing of pre-messenger RNAs is a mechanism common to almost all eukaryotes to generate a plethora of protein variants out of a limited number of genes (Matlin et al, 2005; Nilsen & Graveley, 2010; Lee & Rio, 2015) . High-throughput studies suggested that not only 95-100% of all multi-exon genes in human are affected (Wang et al, 2008; Pan et al, 2008; Gerstein et al, 2014) but also that alternative splicing patterns strongly diverged between vertebrate lineages implying a pronounced role in the evolution of phenotypic complexity (Merkin et al, 2012; Barbosa-Morais et al, 2012) . Five types of alternative splicing have been identified to contribute to most mRNA isoforms, which are differential exon inclusion (exon skipping), intron retention, alternative 5' and 3' exon splicing, and mutually exclusive splicing (Nilsen & Graveley, 2010; Wang et al, 2008; Pan et al, 2008; Blencowe, 2006) .
Mutually exclusive splicing generates alternative isoforms by retaining only one exon of a cluster of neighbouring internal exons in the mature transcript and is a sophisticated way to modulate protein function (Letunic et al, 2002; Meijers et al, 2007; Pohl et al, 2013; Tress et al, 2016) . The most extreme cases known so far are the arthropod DSCAM genes, for which up to 99 mutually exclusive exons (MXEs) spread into four clusters were identified (Schmucker et al, 2000; Lee et al, 2010; Pillmann et al, 2011) .
Opposed to arthropods, vertebrate MXEs have been reported to only occur in pairs (Matlin et al, 2005; Gerstein et al, 2014; Abascal et al, 2015a) , and genome-wide estimates in human range from 118 (Suyama, 2013) to at most 167 cases (Wang et al, 2008) . Despite these relatively few reported cases, mutually exclusive splicing might be far more frequent in humans than currently anticipated, as has been recently revealed in the model organism D.melanogaster . Apart from their low number, MXEs have been described in many crucial and essential human genes such as in the α -subunits of six of the ten voltage-gated sodium channels (SCN genes) (Copley, 2004) , in each of the glutamate homology and many neighbouring exons with high sequence similarity are not spliced in a mutually exclusive manner.
In a first attempt to chart an atlas of genome-wide mutually exclusive splicing in humans, we decided to predict potential MXE candidates and validate those using published RNA-seq data. In a first step, we generated a set of MXE candidates in the human genome (v. 37 .3) from all annotated protein-coding exons and from novel exons predicted in intronic regions including only internal exons in the candidate list ( Fig. 1A, Supplementary Figs . S1 to S4). From the annotated exons we selected those that appeared mutually exclusive in transcripts, and neighbouring exons that show sequence similarity and are translated in the same reading frame. To generate novel exon candidates we predicted exonic regions in neighbouring introns of annotated exons based on sequence similarity and similar lengths (Pillmann et al, 2011) . We did not consider potential MXEs containing in-frame stop codons such as the neonatal-specific MXE reported for the sodium channel SCN8A (Zubović et al, 2012) , and exons overlapping annotated terminal exons ( Supplementary Fig. S2 ). The reconstruction resulted in a set of 6541 MXE candidates in 1542 protein-coding genes, including 1058 (68.6%) genes for which we predicted 1722 completely novel exons in previously intronic regions ( Fig. 1B ). Most introns in human genes are extremely long necessitating careful and strict validation of the MXE candidates to exclude false positive predictions (Lee & Rio, 2015) .
To validate the predicted MXE candidates we made use of over 15 billion publically available RNA-seq reads, selecting 515 samples comprising 31 tissues and organs, 12 cell lines, and 7 developmental stages (Barbosa-Morais et al, 2012; Tilgner et al, 2012; Yan et al, 2013; Xue et al, 2013; Fagerberg et al, 2014) ( Supplementary Table S1 ).
The data were chosen to encompass common and rare potential splice events in a broad range of tissues, cell types, and embryonic stages. Accordingly, the transcription of 6466 (99%) of -6 -the MXE candidates is supported by RNA-seq reads mapped to the genome ( Supplementary   Fig. S3A ). To be validated as true mutually exclusive splicing event, each MXE of a cluster needed to exhibit splice junction (SJ) reads from every MXE to up-or downstream gene regions bridging the other MXE(s) of the cluster (Fig. 1A) . In addition, MXEs should not exhibit any SJ reads to another MXE except when the combined inclusion causes a frameshift and therefore a premature stop codon ( Fig. 1A, Supplementary Figs. S3D, S5 , and S6). These stringent criteria define a high-confidence set of MXEs, requiring three constraints for a cluster of two MXEs and already 18 constraints for a cluster of five MXEs ( Supplementary   Fig. S7 ). In case of clusters with more than two MXE candidates the validation criteria were applied to the cluster including all MXE candidates as well as to all possible sub-clusters to identify the largest cluster fulfilling all MXE criteria. According to these criteria, 1399 MXEs were verified with at least one SJ read per exon (1SJ), supported by 2.2 million exon mapping and 34 million SJ reads, increasing the total count of human MXEs by almost an order of magnitude (158 to 1399) ( Fig. 1B , Supplementary Table S2 ). 855 MXEs were found to be supported by at least 3 splice junction reads per exon (3SJ) validated by 1.5 million exon mapping and 27 million SJ reads (Supplementary Figs. S8 to S10). The 1399 (855, numbers in brackets refer to the 3SJ validation) verified MXEs include 122 (112) annotated MXEs (Fig. 1B 'annotated MXE') , 623 (388) exons that were previously annotated as constitutive or differentially included ('annotated other splicing'), and 654 (358) exons newly predicted in intronic regions ('novel exon'). Our analysis also showed that 29 of the 158 annotated MXEs are in fact not mutually exclusively spliced but represent constitutively spliced exons or other types of alternative splicing ( Supplementary Fig. S2 ). Finally, 1741 (2336) MXE candidates including 1090 (1402) newly predicted exons and 17 (29) of the annotated MXEs are supported by 0.5 million exon and 13 million SJ matching reads but still have to be regarded -7 -as MXE candidates because not all annotation criteria were fulfilled (Supplementary Figs. 3A and 3E).
To estimate the dependence of MXE confirmation and rejection on data quantity we cross-validated the MXE gain (validation) and loss (rejection) events for several subsets of the total RNA-seq data ( Fig. 1C and Supplementary Fig. S11 ). The course of the curves provides strong evidence for the validity of the MXEs because a single exon-joining read would already be sufficient to reject an MXE cluster while at least two SJ reads are needed to validate one. Whereas even 15 billion RNA-seq reads do not achieve saturation for the amount of validated MXEs, the gain in rejected MXE candidates is virtually saturated using 25% of the data. In summary, the high-confidence set of 1399 (855) MXEs extends current knowledge of human MXE usage by an order of magnitude, (re)-annotating over a thousand existing and predicted exons and isoforms, while suggesting the existence of further human MXEs.
The human genome contains large cluster and multi-cluster MXEs
In general, mutually exclusive splicing can be quite complex. This is best demonstrated by genes in arthropods that contain both multiple MXE clusters ('multi-cluster') and large clusters with up to 53 MXEs such as in the Drosophila Dscam genes (Graveley et al, 2004; Pillmann et al, 2011) . This is in strong contrast to mutually exclusive splicing in vertebrates as there is to date no evidence of multi-cluster or higher order MXE clusters (Matlin et al, 2005; Wang et al, 2008; Pan et al, 2008; Gerstein et al, 2014; Abascal et al, 2015a Abascal et al, , 2015b .
The analysis of the 1399 validated human MXEs provides first evidence for clusters of multiple MXEs in the human genome ( Fig. 1D, Supplementary Fig. S12 interleaved mutually exclusive splicing can be seen for CUX1, the transcription factor Cutlike homebox 1. It contains a cluster of MXEs (exons 3b -3e) that is differentially included into a set of two exons (exon 3 and exon 4), and the two sets are themselves mutually exclusive ( Fig. 1F , Supplementary Figs. S13 and S14). The identification of large clusters with multiple MXEs and many genes with multiple clusters shows that complex mutually exclusive splicing is not restricted to arthropods (Schmucker et al, 2000; Graveley, 2005; Lee et al, 2010; but might be present in all bilateria.
Mutually exclusive splicing is tightly regulated at the RNA and protein level
To gain mechanistic insights into the regulation of mutually exclusive splicing in humans we investigated four mechanisms that were shown to act in some specific cases and were proposed to coordinate mutually exclusive splicing in general ( Fig. 2A ) (Letunic et al, 2002; Smith, 2005) . We identified six cases (0.95%) of U2 and U12 splice acceptor incompatibility ( Supplementary Fig. S15 ), 57 cases of a too short distance between splice donor sites and branch points (< 50 bp), and 377 (60%) cases of frame-shift that would result in nonfunctional mRNAs in case of combined inclusion (Supplementary Figs. S16 and S17). MXEjoining reads were found for 83 (22%) of these MXE clusters, 91 (75%) of the annotated and 25 (4%) of the predicted MXEs, suggesting that splicing of the remaining MXE clusters is tightly regulated by other mechanisms (Fig. 2B , Supplementary Figs. S3A, S3D) such as RNA-protein interactions, interactions between small nuclear ribonucleoproteins and splicing factors (Lee & Rio, 2015) , and competitive RNA secondary structural elements (Graveley, 2005; Yang et al, 2012; Suyama, 2013; Lee & Rio, 2015) ( Supplementary Fig. S18 ).
In contrast to cassette exons and micro-exons, which tend to be located in surface loops and intrinsically disordered regions instead of folded domains (Buljan et al, 2012; Ellis et al, 2012; Irimia et al, 2014) , all MXEs, whose structures have been analysed, are embedded within folded structural domains as has been shown for e.g. DSCAM (Meijers et al, 2007) ,
H2AFY (Abascal et al, 2015a) , the myosin motor domain , and SLC25A3 (Tress et al, 2016) . As we have shown in the beginning and have shown for
Drosophila , there is also a subset -of unknown size -of MXEs not showing any sequence homology. If the exons of this subset were true MXEs and not misclassified because of so far missing exon-joining reads, it would seem unlikely that the encoded peptides are part of the same folded domains. Here, we focused on exons with similar length and sequence similarity. Because of this similarity we assumed that MXEs modulate protein functions through variations in specific restricted parts of the structure as has been pointed out before (Tress et al, 2016) . We identified three parameters that (Rose et al, 2015) . In 87% of the 543 MXEs matched to human or mammalian -10 -protein structures at least one of the exon termini is embedded within a secondary structural element, supporting the hypothesis that MXEs modulate but do not considerably alter protein functions (Letunic et al, 2002; Yura et al, 2006; Abascal et al, 2015a; Tress et al, 2016) ( Supplementary Fig. S19 , Supplementary Table S3 ). Of the remaining 13% (blue colour in Fig. 2C ), many MXEs would lead to frame shifts if they were cassette exons (blue circles), and in multiple cases (e.g. COL9A3, COL24A1, and COL13A1) the peptide ends are far apart indicating strong folding problems in case the respective exons were absent in the transcripts.
In total, there are only a handful cases such as the MXE cluster in ARL15 (Fig. 2C ) whose mutually exclusive presence in proteins cannot be explained by the analysed splicing restrictions, by NMD-targeting, or by folding constraints.
MXEs mainly consist of one ubiquitous exon and otherwise regulated exons
To modulate gene functionality, mutually exclusive splicing would need spatial and temporal splicing regulation and expression (Wang et al, 2008; Tress et al, 2016) . To understand the expression patterns of MXEs we conducted a differential inclusion analysis using the Human Protein Atlas (Fagerberg et al, 2014) , Embryonic Development (Yan et al, 2013) , and ENCODE datasets (Diebold et al, 1992) , an example for the switch of expression are the MXEs of the SLC25A3 gene (Wang et al, 2008) . We surmise that the observed specificity in combination with a generally lower expression could also explain the discovery of 654 (358) novel exons that have so far eluded annotation efforts ( Fig. 1A , Supplementary Fig. S20 ). In conclusion, the tight developmental and tissue-specific regulation of MXE expression suggests that changes in MXE function or expression might cause aberrant development and human disease (Xiong et al, 2015) . Pathogenic mutations in MXEs are known to cause Timothy syndrome, cardiomyopathy, cancer, and kidney disease (Splawski et al, 2004 (Splawski et al, , 2005 Mayr et al, 2011; David et al, 2010; Kaplan et al, 2000) .
MXEs are high-susceptibility loci for pathogenic mutations
To obtain a comprehensive overview of MXE-mediated diseases we annotated all MXEs with -12 -pathogenic SNPs from ClinVar (Landrum et al, 2016) , resulting in 35 MXEs (eight newly predicted exons) with 82 pathogenic SNPs ( Fig. 4 , Supplementary Table S5 ). Diseaseassociated MXEs show tight developmental and tissue-specific expression (average Giniindex of 0.65) with prominent selective expression in heart and brain, and cancer cell lines ( Fig. 4C , Supplementary Table S4 ). Interestingly, the percentage of genes with MXEs, which carry pathogenic SNPs, of all genes with MXEs is two-fold higher than the percentage of pathogenic SNP-carrying genes of all other genes. The genes with MXEs carrying pathogenic SNPs are predominantly associated with neurological disease (10), neuromuscular disorders (7), cardiomyopathies (6), and cancer (3), and are enriched in voltage-gated cation channels (e.g. CACNA1C-D), muscle contractile fiber genes (e.g. TPM1), and transmembrane receptors (e.g FGFR1-3) ( Fig. 4 , Supplementary Fig. S24 , Supplementary Table S5 ).
Disease-associated MXEs have high amino-acid identity (average 49.1%, SD 23.1%), reaching up to 89% in ACTN4, suggesting similar functional roles and in consequence similar pathogenic potential for many MXE pairs ( Fig. 4C , Supplementary Fig. S25 ). It is therefore surprising that only four of all SNP-containing MXE clusters contain mutations in both MXEs Of the 35 MXE clusters with pathogenic mutations eight contain novel exons ( Fig. 4C , Supplementary Table S6 ). A mutation in exon 9a (p.Asp365Gly) of FAR1, a gene of the plasmalogen-biosynthesis pathway, causes Rhizomelic chondrodysplasia punctata (RCDP), a disease that is characterized by severe intellectual disability with cataracts, epilepsy, and growth retardation (Buchert et al, 2014) . Novel MXE 9b is expressed in the same tissues but at 8-fold lower levels suggesting partial functional compensation of the MXE 9a mutation, which might be responsible for the 'milder' form of RCDP as compared to pathogenic mutations in other genes of the pathway (PEX7, GNPAT, and AGPS) ( Supplementary Fig.   S29 ). A tissue-specific compensation mechanism had already been proposed but a reasonable explanation could not be given because FAR2 expression shows a different tissue profile and individuals with deficits in peroxisomal β -oxidation, a potential alternative supply for fatty alcohols, have normal plasmalogen levels (Buchert et al, 2014) . Because of the young age of the affected children it is not known yet, whether a mutation in constitutive exon 4 (p.Glu165_Pro169delinsAsp), which could not be compensated in a similar way as the exon 9a mutation, leads to a strong RCDP-like phenotype (no survival of the first decade of life) or to a milder form such as the one caused by the exon 9a mutation.
In conclusion, it is tempting to speculate that MXE pathogenicity might be governed by high or exclusive expression in affected target tissues that is usually absent from early developmental processes, a pattern of expression that seems at least partially inversed for MXEs without pathogenic SNP annotations. To assess whether MXE pathogenicity follows observable rules we trained a machine learner on MXE expression data and predicted the affected target tissue ( Fig. 4D , Supplementary Table S6 ). To obtain at least ten observations -14 -per category with an expression > 3 RPKM, diseases were grouped into cardio-neuromuscular (n=10) and other diseases (n=14) and predicted using leave-one-out cross-validation with a Random Forest. Cardiac-neuromuscular diseases could be predicted with an accuracy of 79% (p-value = 0.03), a specificity of 71%, a sensitivity of 90% and an area under the ROC curve (AUC) of 79% ( Fig. 4D , Supplementary Table S6 ). Although based on only 24 observations, our data suggests that MXE expression might predict disease pathogenicity in space and potentially also in time.
Rapid gain and loss of MXEs in mammalian evolution
While tissue-specific gene expression is conserved between birds and mammals, the alternative splicing of differential inclusion exons is conserved only in brain, heart and muscles and is mainly lineage-specific (Merkin et al, 2012; Barbosa-Morais et al, 2012) .
Accordingly, a core of only ~500 exons was identified with conserved alternative splicing in mammals and high sequence conservation. In contrast, most of the known human MXEs have been shown to be highly conserved throughout mammals if not even vertebrates (Letunic et al, 2002; Copley, 2004; Abascal et al, 2015b) . In order to assess the conservation of human MXEs across mammals we identified orthologous proteins in 18 representative species from all major sub-branches spanning 180 million years of evolution and predicted MXEs therein ( Fig. 5 , Supplementary Fig. S30 , Supplementary Table S7 ). Based on a simple model expecting each shared cluster to be already present in the last common ancestor of the respective species, the evolution of the MXE clusters is characterised by a core set of at least 173 (28%) of the human MXE clusters conserved throughout mammals ( Fig. 5 , Supplementary Fig. S30 ). These MXE clusters include 83 clusters shared between at least 16 of the species and 61 clusters shared between 17 species while the other MXEs are subject to branch-and species-specific cluster gain and loss events. The clusters absent in specific -15 -branches most likely do not represent cases of missing data but taxon-specific loss events, such as the MXE clusters in the SRPK1 and PQBP1 genes, which are absent in Glires (including mouse and pika), the cluster of ten MXEs in ABI3BP that has been lost in the ancestor of mouse and rat, the MXEs in OSTF1 and PTPRS, which are absent in Afrotheria, and the MXE clusters in IKZF3, MBD1 and ATP10B, which are present in all Eutheria (16 species, placental mammals) but not in Metatheria (marsupials). The MXE cluster gain rate within eutherian evolution towards human is relatively constant over time with about 23 clusters per 10 million years. Interestingly, the 16 eutherian species lost similar numbers of MXE clusters compared to human (127 clusters on average, Supplementary Fig. S30 ).
Although the overlap of MXEs in orthologous genes of human and Drosophila is very low
and their presence has been attributed to convergent evolution (Copley, 2004) , the MXE gain and loss rates are very similar indicating a conserved role of tandem exon duplication in bilaterians. Gene structures can be highly conserved between kingdoms (Rogozin et al, 2003) and certain exons therefore seem to be predisposed to undergo duplication. In summary, these findings provide strong evidence for many MXE gain and loss events during mammalian evolution, suggesting a pronounced role of these processes in speciation and establishing phenotypic differences.
Discussion
Using stringent criteria, including sequence similarity, reading frame conservation and similar lengths, and billions of RNA-seq reads we generated a strongly validated atlas of 1399 human MXEs providing insights into mutually exclusive splicing mechanics, specific expression patterns, susceptibility for pathogenic mutations, and deep evolutionary conservation across 18 mammals. The presented increase of human MXEs by an order of magnitude lifts MXEs into the present-day dimension of other human alternative splice types (Wang et al, 2008; Pan -16 -et al, 2008; Gerstein et al, 2014) . Saturation analysis and the existence of 1816 expressed but unconfirmed MXE candidates promise a potential two-fold increase of the MXE-ome with further sequence data incorporated. Although alternative splice variants are abundant at the transcriptome level, recent mass spectrometry analyses suggested only small numbers of alternative transcripts to be translated (Ezkurdia et al, 2015; Abascal et al, 2015a) .
Interestingly, MXEs were particularly enriched in the translated alternative transcripts, compared to other splice variants. However, ribosome profiling data showed high frequencies of ribosome engagement of cassette exons indicating that these isoforms are likely translated (Weatheritt et al, 2016) . Similar results have been obtained through polyribosome profiling (Sterne-Weiler et al, 2013; Floor & Doudna, 2016) . These observations suggest that most of the MXEs evaluated at the transcript level will also be found in the proteome.
About half (47%) of the 1399 MXEs represent novel exons, which are often expressed at low levels and whose expression is restricted to few tissues and cell-types, possibly explaining their absence from current genome annotations. Extrapolating these observations to all splice types and genes suggests the existence of thousands yet unannotated exons in introns. This estimation is in accordance with a recent analysis of more than 20000 human RNA-seq datasets that revealed over 55000 junctions not present in annotations (Nellore et al, 2016) . In this analysis, junctions found in at least 20 reads across all samples were termed 'confidently called'. Although the total number of reads required for MXE validation in our analysis is lower (≥ 2 SJ reads in the 1SJ case, ≥ 6 SJ reads in the 3SJ case), the numbers seem more conservative given that we used 40 times less datasets for the validation.
The almost ten-fold increase in the human MXE-ome supports recent suggestions that mutually exclusive splicing might play a much more frequent role than anticipated (Wang et al, 2008; Pan et al, 2008; Ezkurdia et al, 2012; Abascal et al, 2015a (Letunic et al, 2002; Tress et al, 2016) .
The concerted annotation and splicing analysis of novel exons has deep implications for the detection and interpretation of human disease (Bamshad et al, 2011; Gonzaga-Jauregui et al, 2012; Xiong et al, 2015; Bowdin et al, 2016) . For one, exome and panel sequencing remain the method of choice for the detection of genetic diseases and both methods rely on current exon annotations (Chong et al, 2015) . Furthermore, our data suggest that MXE expression might reflect disease pathogenesis that could allow for the prediction of the affected organ(s). It is intriguing to speculate that the observed expression-disease association is a general dogma, which could be used to predict yet unseen diseases from published expression data, potentially bringing about a paradigmatic shift in (computational) disease research.
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Materials and Methods

Data sources
The human genome assembly and annotated proteins (all isoforms) were obtained from GenBank (v. 37.3) (Benson et al, 2013) . For MXE candidate validation, we selected data from 515 publically available samples comprising 31 tissues and organs, 12 cell lines, and 7 developmental stages (Barbosa-Morais et al, 2012; Tilgner et al, 2012; Djebali et al, 2012; Yan et al, 2013; Xue et al, 2013; Fagerberg et al, 2014) amounting to over 15 billion RNAseq reads. The data were chosen to encompass common and rare potential splice events in a broad range of tissues, cell types, and embryonic stages. These RNA-seq data were obtained from either GEO (NCBI) or ENA (EBI) databases ( Supplementary Table S1A ). The description of the respective tissues and developmental stages is listed in Supplementary   Table S1B .
Reconstruction of gene structures
The gene structures for the annotated proteins were reconstructed with Scipio (Keller et al, 2008; using standard parameters except --max_mismatch=7,
--blat_identity=54, --exhaust_align_size=20000, and --exhaust_gap_size=50. We let Scipio start with blat_tilesize=7 and, if the entire gene structure could not be reconstructed, reduced the blat_tilesize step by step to 4. All parameters are less stringent than default parameters to increase the chance to reconstruct all genes automatically.
Predicting mutually exclusive spliced exons
The human genome annotation does not contain specific attributes for alternative splice variants and thus does not allow extracting or obtaining lists for specific splice types. As Fig. S4 ). This list might be of interest for further investigation for other researchers. Except for this Supplementary Fig. S4 , we entirely focused on internal MXE candidates.
Definition of criteria for RNA-seq evaluation of the MXE candidates
While the sole mapping of RNA-seq reads reveals the transcription of the respective genomic region it does not prove the inclusion into functional transcripts. The mutually exclusive inclusion of the MXE candidates into functional transcripts requires at least the following splice junction (SJ) reads ( Supplementary Fig. S5 ): A) There must be SJ reads matching from every MXE to up-or downstream gene regions bridging the other MXEs of the cluster. The latter criterion takes into account that the annotated exons neighbouring the clusters of MXEs might not themselves be constitutive but alternative exons as for example in NCX1
( Supplementary Fig. S6) . B) SJ reads mapping from one to another MXE candidate lead to MXE candidate rejection except for those MXEs leading to a frame shift. Without this constraint, which has not been set in earlier analyses (Wang et al, 2008) MXEs cannot be distinguished from neighbouring differentially included exons, which are quite common in human (data not shown; see for example (Hammesfahr & Kollmar, 2012) and Supplementary -21 - Fig. S6 ). Thus, there are three constraints for a cluster of two MXEs while clusters of three and five MXEs, for example, already require seven and 18 constraints, respectively ( Supplementary Figs. S5 and S7 ). Under more stringent conditions, also SJ reads from MXEs to the neighbouring annotated exons independent of their splice type would be required giving rise to five constraints for a cluster of two MXEs ( Supplementary Fig. S5 ).
Note that as a matter of principle the read coverage of every single MXE is considerably lower than that of constitutive exons due to their mutually exclusive inclusion in the transcripts. For example, each of the exons of a cluster of three MXEs is expected to only have, on average, one-third the coverage of the constitutive exons of the same gene. The number of predicted exons, of which both sites are supported by splice junction reads, is also considerably lower than the total number of supported MXE candidates ( Supplementary Fig.   S3 ), which we think is due to the general low coverage of the exons and not due to read mapping and exon border prediction problems ( Supplementary Fig. S3 ).
Validation of the MXE candidates by RNA-seq mapping
SRA files were converted to FASTQ files using fastq-dump software (v. 2.1.18). FASTQ files were mapped onto the human reference genome (hg19) using the STAR aligner (v_2.3.0e_r291) (Dobin et al, 2013) . To this end, we first generated a reference genome index with --sjdbGTFfeatureExon, --sjdbGTFtagExonParentTranscript, a splicejunction overhang size of 99 (--sjdbOverhang) and GTF annotation files containing all transcripts and all MXE candidates. The MXE candidate GTF file was extracted from Kassiopeia database and is available for download there . The mapping was done for each sample separately. We allowed a rather stringent maximum mismatch of 2 (--outFilterMismatchNmax 2; STAR default is 10) and the output was forced to SAM format (--outStd SAM). Otherwise, default settings were used. The -22 -resulting files with the mapped reads were sorted, converted to BAM format and indexed with SAMtools (sort -n) for further processing (Li et al, 2009 ).
Distinguishing MXEs from other splice variants
For the analysis of the read mapping data we disassembled clusters with more than two MXE candidates into all possible sub-clusters. E.g. a cluster with four MXE candidates [1, 2, 3, 4] was fractionated into the following sub- Each of these sub-clusters was analysed independently according to the validation criteria (splice junction reads present, exon joining reads absent). If all criteria were satisfied for one of the sub-clusters, all MXE candidates of the respective sub-cluster were labelled "verified".
In a second analysis, each cluster of MXE candidates was analysed for exon joining reads, which denote constitutive splicing or splicing as differentially included exons. However, MXE candidates of clusters and sub-clusters with exon joining reads but exon lengths not divisible by three were also flagged as "verified" because their combined inclusion would lead to a frame-shift in the translation of the transcript.
Limits of the MXE dataset
Similar to every genome annotation dataset, also the current dataset of RNA-seq validated MXEs has some limitations. Some are inherent to the still incomplete human genome annotation that was used as basis for generating the list of MXE candidates. As mentioned above and shown in Supplementary Fig. S2C , there are genes with mis-annotated terminal exons overlapping MXEs. Also, there are "transcripts" in the GenBank dataset that combine exons from (now) different genes. The presence of these "transcripts" in the genome annotation might be the result of mis-interpreting cDNA data as coding sequence although these might be the result of some level of mis-splicing.
-23 -Similarly, mis-splicing might be an important reason for validating true MXEs as "non-MXEs". A single exon-joining read turns MXE candidates into non-MXEs, whose mutually exclusive splicing might otherwise be supported by thousands of MXE-bridging SJ reads. Given these limitations we expect that many of the exons, that we currently tag as constitutive or other alternative splicing, might in fact be MXEs. On the other hand, our MXE dataset might also contain some exons, that are in fact non-MXEs. This is well demonstrated in the saturation analysis (Fig. 1C) showing that although more data will lead to the validation of many more exons as MXEs, for which SJ reads are currently missing, there will be clusters that will be rejected as soon as more data include exon-joining reads. In addition, some MXEs with only a few supporting SJ reads might in fact be pseudoexons. However, we also did not observe any SJ reads for about 15% of the annotated exons, which are nevertheless not regarded as pseudoexons ( Fig. 1B, Supplementary Fig. S3 ). Finally, some MXEs determined from transcripts showing complex splicing might in fact be mutually exclusive in transcripts, but not in the sense of a cluster of uninterrupted neighboring exons.
Saturation Analysis
Sub-samples of STAR-aligned RNA-seq splice junction (SJ) reads were used to estimate the expected recall and false positive rate. The number of verified MXEs was calculated using SJ reads for different percentages of the data. To reduce the bias from data sampling, datasets were chosen randomly and the saturation analysis was performed in 30 independent runs. To calculate the mean of validated and rejected MXEs at respective percentages of the total RNA-seq data used for validation, we used the respective numbers from the 30 independent runs.
Analysis of the splice mechanism
-24 -
To determine the distance between intron donor site and branch point we analysed all introns smaller than 500 bp using the standalone version of SVM-BPfinder (beta) (Corvelo et al, 2010) to predict branch point locations. Longer introns harbour high numbers of branch point candidates and the accuracy of the branch point prediction considerably decreases. Longer introns also often contain multiple branch points with different splicing kinetics (Corvelo et al, 2010) so that a steric hindrance criterion for splicing multiple MXEs into the same transcript might not apply anymore. Branch points are usually located in the 3' regions of the introns and it seems highly unlikely to identify only a single potential branch point within an e.g. >2000 bp intron, which would in addition be located within the 5' 50 bps. Thus, the highest-scoring location within the <500 bp introns was taken as best guess for the branch point and the distance to the intron donor site determined.
In order to identify U12-type introns we analysed all donor splice sites of the introns preceding the clusters of MXEs and those subsequent to all MXEs using the consensus pattern described by Sharp and Burge (Sharp & Burge, 1997) . The acceptor splice sites of U12-type introns do not show conserved patterns and were therefore not used here for verification.
Binding windows for competing intron RNA secondary structures were predicted for all candidate clusters of MXEs using the SeqAn package (Döring et al, 2008) . The identified binding windows of all homologous genes were aligned using MUSCLE (Edgar, 2004 ) and the RNA secondary structures predicted by RNAalifold (ViennaRNA package) (Lorenz et al, 2011) .
Mapping MXE sequences onto protein structures
To identify the best structural models for the sequences encoded by the MXEs we mapped the protein sequences of the respective genes against available protein structure data. To this end, Consortium, 2015) or
GenBank (Benson et al, 2013) and the corresponding gene structures of the eukaryotic proteins reconstructed with WebScipio . In Allora, all PDBs belonging to the same UniProt or GenBank entries are connected. BLAST+ (Camacho et al, 2009 ) was used to search for the most similar UniProt/GenBank protein sequence compared to the human proteins containing MXEs. The hit with the lowest E-value was taken and the associated PDB chains were aligned to the human protein using m-coffee (Wallace et al, 2006) . The MXE part of the alignment was extracted for further analysis (=> "MXE structure"). As "intron distances" we determined the distances between the CA-atoms of the first and the last residues of the MXE-structures.
Evaluating the differential inclusion of MXEs into transcripts
Read counts for both genes and exons were extracted using HTSeq-count v. 0.6.1 ( (high expression specific/novel/SNP-containing MXE) (see also Fig. 3a, Supplementary Fig.   S20 , and Fig. 4c ). In case an MXE pair was not expressed in a certain tissues (NA or 0) the value was set to 0.
Inequality analysis
The (Cowell, 2011) . For the analysis of MXE clusters only those clusters were taken into account that include at least two MXEs with an RPKM ≥ 10 in at least one dataset within each project (318, 120, and 273 clusters, respectively).
Identification of pathogenic SNPs in MXEs
In order to identify potentially pathogenic SNPs in MXEs, the MXEs were compared to the ClinVar SNP database (ClinVar VCF file downloaded on 11 Aug 2016, version updated at 30
Jun 2016, (Landrum et al, 2016) or bias several crucial steps were taken. First, we did not optimize hyper-parameters, using a Random Forest with 250 trees and a maximum tree depth of 16 (number of predictors / 3).
Second, we used leave-one-out cross-validation to avoid sampling bias and model instability.
Third, diseases were grouped into two categories of relatively even size (see above).
Models were built using the R packages caret (Kuhn, 2008) and randomForest and ROC curves were generated with ROCR (Sing et al, 2005) .
Gene Ontology enrichment analysis
We used WebGestalt for Gene Ontology enrichment analyses (Wang et al, 2013) . The lists of unique genes in gene symbol format were uploaded to WebGestalt and the GO Enrichment Analysis selected. The entire human genome annotation was set as background and 0.05 as threshold for the p-value for the significance test using the default statistical method "hypergeometric".
Protein interaction analysis
The protein-protein interaction network was built by using GeneMANIA webservice (Warde-Farley et al, 2010) . The list of unique genes containing a pathogen SNP was submitted to
GeneMANIA's webservice and we downloaded the resulting network in SVG format and manually included disease and ontology information.
Assessing the dynamics of MXE annotations over time
MXEs might have already been annotated/described although not been included in the NCBI reference dataset. This might especially account for newer annotations based on the recently published ENCODE project data. Therefore, we obtained alternative protein sequence datasets from Aceview (Thierry-Mieg & Thierry-Mieg, 2006) and Ensembl (Yates et al, 2016) . Further datasets like the VEGA and GENCODE annotations are continuously integrated into Ensembl and were therefore not considered separately. The Aceview database has been built in the year 2000 to represent comprehensive and non-redundant sequences of all public mRNA sequences. The human dataset has last been updated in November 2011, thus before the availability of the ENCODE data.
To assess the novelty of our MXE assignments with respect to the timely updates and changes of the human annotations we compared our data with that of Aceview and with the latest annotation from Ensembl (Fig. 5, Supplementary Fig. S1 ). As at the beginning of the project, only a few MXEs are annotated as such in other databases. Surprisingly, however, many of the previously annotated exons (independent of their splicing status) were removed from the latest Ensembl annotation, although our RNA-Seq mapping not only strongly -30 -supports their inclusion into transcripts but also their splicing as MXEs. This shows that further collaborative efforts are needed to reveal a stable and persistent human gene annotation.
Ab inito exon prediction
Exon prediction by ab initio gene finding software is another means of generating a database of potential coding sequences. Ab initio exon prediction was done with AUGUSTUS (Stanke & Waack, 2003) using default parameters to find alternative splice forms and the feature set for Homo sapiens.
Identifying orthologous proteins in 18 mammals
Cross-species searches in 18 mammals ( Supplementary Table S7 ) were done with WebScipio to be already present in the last common ancestor of the respective species. This approach is equivalent to inferring ancestral character states with Dollo parsimony (Farris, 1977) .
Data availability
-31 -All generated data can be searched, filtered and browsed at Kassiopeia (www.motorprotein.de/kassiopeia; ). The datasets supporting the conclusions of this article are also included within the article and its additional files.
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Figure legends
Figure 3 -MXE expression is tightly regulated across tissues and development. A)
Heatmap showing all differentially expressed MXE clusters with at least 3 RPKM. Here, we used the Gini coefficient, which is a measure of the inequality among values of a frequency distribution (Ceriani & Verme, 2012) and has successfully been used to determine tissueenriched gene sets (Zhang et al, 2017) , to determine highly tissue-specific MXEs (maximum -41 - 
